论文信息 - Clinical and demographic characteristics predictive of treatment outcomes for certolizumab pegol in moderate to severe Crohn's disease: analyses from the 7‐year PRECiSE 3 study - 字舞流文

Clinical and demographic characteristics predictive of treatment outcomes for certolizumab pegol in moderate to severe Crohn's disease: analyses from the 7‐year PRECiSE 3 study

Judy H. Cho | M. Regueiro | D. Schwartz | D. McGovern | C. Siegel | W. Sandborn | E. Loftus | B. Abraham | G. Lichtenstein | C. Randall | J. Coarse | M. Spearman | G. Košutić | S. D. Lee | A. Gutierrez | B. Pierre-Louis | G. Melmed | Scott D. Lee | J. H. Cho | S. Schreiber | B. Abraham | D. A. Schwartz | S. Schreiber | W. Sandborn | J. M. Choi | G. Lichtenstein | M. Spearman | G. Kosutic | B. Pierre‐Louis | J. Coarse | S. Lee | J. Choi | Alexandra M. Gutierrez | Judy H. Cho